What Researchers Did
The researchers searched medical databases for randomized trials that tested whether adding hyperbaric oxygen therapy (HBOT) to usual care helps diabetic foot ulcers heal and prevents amputations.
What They Found
This systematic review of seven randomized trials (376 patients) found some evidence of improved healing with HBOT in ischaemic diabetic foot ulcers, but no clear benefit in non-ischaemic ulcers. Two trials in ischaemic ulcers reported higher rates of complete healing at 1 year (number needed to treat 1.8 and 4.1), but no difference in amputation rates. A third trial in ischaemic ulcers reported lower major amputation rates with HBOT (number needed to treat 4.2) and did not report on healing. None of the trials in non-ischaemic ulcers (64 patients) reported differences in healing or amputation rates. Two trials with unknown ulcer types reported lower amputation rates, though the largest used a different definition for both outcomes. HBOT did not change the need for additional interventions.
What This Means for Canadian Patients
For people with diabetic foot ulcers, this review found some evidence of benefit when the ulcer was ischaemic, meaning blood flow was reduced. It found no reported benefit in non-ischaemic ulcers. Only two of the seven trials were of good methodological quality, so patients should talk with their care team about what the evidence does and does not show.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The trials differed too much to be pooled, only two were of good methodological quality, and the authors state that larger, higher-quality trials are needed before HBOT can be justified for routine use in diabetic foot ulcers.